Opinion
Verve Therapeutics (VERV) - Gene-Based Revolution in Cholesterol Treatment on the Brink of a Breakthrough?
I am optimistic about the recent clinical successes at Verve Therapeutics! The Phase 1b results of...
Five Reasons Why I Remain Convinced by 2G Energy!
The stock of 2G Energy (i) (WKN A0HL8N) is currently one of my favorite small-cap stocks in the German...
Novo Nordisk is Receding – but the Comeback Potential is Great
Novo Nordisk has recently had setbacks - disappointing study results and the growing success of Eli Lilly...
Altria: A Solid Protection Against Trump's Tariffs
The Altria Group (NYSE: MO) is a holding company that engages in the manufacture and sale of tobacco...
GOLD - A Brilliant Growth Story With Record Potential by the End of 2025!
I am convinced that gold continues to be on a remarkable upward trend. I consider Goldman Sachs ' forecast...
Dell Technologies: Temporary Relief in Tariff Conflict Positive in the Short Term
Dell Technologies (DELL) is one of the top beneficiaries of the 125% US tariffs exemption against China....
Digital Policy is Power Policy. Ionos is the Top Beneficiary of Germany's Pursuit of Digital Sovereignty!
I followed with interest the perspectives on "Digital" in the new coalition agreement. The Union and...
Constellation Energy is Exciting Again After the Correction!
Constellation Energy stock offers an attractive ratio of potential opportunities to risks given the sell-off...
SCHOTT Pharma: Here's why I have Opened a Position
Market uncertainty has significantly increased due to US tariff policies and a potentially escalating...
TSMC: The Indispensable Chip Maker for the AI Revolution!
I see TSMC as the key player in the entire semiconductor industry. With an impressive 67% market share...
The AppLovin Stock is now Interesting for an Initial Tranche!
The AppLovin stock has experienced rapid development, but Morgan Stanley now sees the right time to buy...
Brinker International: The Upcoming Q3 Figures are Likely to be Impressive!
Brinker International (NYSE: EAT) is expected to continue the positive trend in customer numbers at...
Northrop Grumman: Should you buy Shares now? Two Reasons for Increasing Demand for Military Goods!
I trust that the stock of Northrop Grumman (NOC) will soon conclude its correction that has been ongoing...
AST SpaceMobile is a top Opportunity Looking Ahead to the Coming Years
With AST SpaceMobile (ASTS), I anticipate a soon-to-come rally towards an all-time high due to recent...
Teradyne: The Company Benefits From More US Factories in two Ways. Projected P/E Ratio of 8.5!
The stock of Teradyne (TER) has caught my attention in the USA, as I believe the risk-reward ratio is...
Luxury Stocks in the Tariff Storm: Pricing Power as a Lifeline in Uncertain Times!
I see luxury stocks as relative islands of stability in the current market environment, despite the...
Intel: Countercyclical Buying Opportunity Thanks to new CEO, TSMC Deal & US Advantage?
On April 8th, the stock of Intel Corp. (INTC) fell to its lowest level in more than a decade. Countercyclically,...
Carvana as a Short-Term Beneficiary of US Tariffs on car Imports
Carvana (CVNA) is an exciting rebound candidate as a leading US online retailer of used cars after a...
Intuitive Surgical (ISRG) – The Pioneer of Robotic Surgery with Enormous Future Potential!
I am convinced that Intuitive Surgical represents an extraordinary investment opportunity in the medical...
Here's Which DAX Stocks I Will buy More of now
Siemens (XETRA: SIE) signed an agreement at the beginning of April to acquire the American scientific...
Cheniere Energy: A Winner of Trump's two-Component Deals!
Donald Trump's statements regarding Vietnam and the EU, both of which want to negotiate in the trade...
Super Micro may now be on the Verge of a Comeback!
Shares of Super Micro Computer surged on Monday, despite the overall market fluctuating due to the uncertainty...
AngioDynamics is likely to quickly reach its all-time high in a favorable market environment
AngioDynamics (ANGO) is undergoing a transformation process and aims to focus on high-growth medical...